Annual Report 11/12

The Diamyd Medical Annual Report for 2011/2012 is now available in English. The annual report is attached as a PDF and is available at

To request a printed annual report, please forward your full name and address to, or to postal address Diamyd Medical AB, Karlavägen 108, 115 26 Stockholm.

For more information, please contact:
Peter Zerhouni, President and CEO Diamyd Medical AB
Phone: +46 8 661 00 26. E-mail:


About Us

Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB. Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Documents & Links